LOS ANGELES TIMES – Despite intense pressure to hold down federal spending, the Defense Department is launching a high-priced effort to create its own production pipeline for vaccines and biodefense drugs – an initiative that defies the advice of government-hired experts and duplicates what another agency is doing.

Continue reading